This article contains links to products or services from one or more of our advertisers or partners. We may receive a commission when you click or make a purchase using our site. Learn more about how we make money.

How to buy IDEAYA Biosciences stock | $13.48

Own IDEAYA Biosciences stock in just a few minutes.

Posted

Fact checked

IDEAYA Biosciences, Inc is a biotechnology business based in the US. IDEAYA Biosciences shares (IDYA) are listed on the NASDAQ and all prices are listed in US Dollars. IDEAYA Biosciences employs 46 staff and has a market cap (total outstanding shares value) of USD$389 million.

How to buy shares in IDEAYA Biosciences

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for IDEAYA Biosciences. Find the stock by name or ticker symbol: IDYA. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until IDEAYA Biosciences reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of USD$13.48, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of IDEAYA Biosciences, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of IDEAYA Biosciences. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

IDEAYA Biosciences share price

Use our graph to track the performance of IDYA stocks over time.

IDEAYA Biosciences shares at a glance

Information last updated 2020-10-19.
Latest market close USD$13.48
52-week range USD$2.95 - USD$19.97
50-day moving average USD$12.7338
200-day moving average USD$10.4408
Wall St. target price USD$24.22
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) USD$-14.66

Buy IDEAYA Biosciences shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee
Vanguard
$0
Stocks, Mutual funds, ETFs, Forex
$1
$20 per year
Get a personal advisor when you open an account with at least $50,000.
Robinhood
$0
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
A free way to invest in stocks, ETFs and crypto.
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, Index funds, ETFs, Futures, Cash
$0 + $0.65/contract, $1 minimum
0%
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
TD Ameritrade
$0
or $25 broker-assisted
Stocks
$0 + $0.65/contract,
or $25 broker-assisted
TD Ameritrade features $0 commission for online stock, but watch out for high short-term ETF and broker-assisted trading fees.
Moomoo
$0 for US stocks
Stocks, Options, ETFs
$0
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
loading

Compare up to 4 providers

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy IDEAYA Biosciences stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

IDEAYA Biosciences price performance over time

Historical closes compared with the close of $13.48 from 2020-11-16

1 week (2020-11-25) 0.90%
1 month (2020-11-06) 1.74%
3 months (2020-09-04) 15.02%
6 months (2020-06-04) 54.06%
1 year (2019-12-04) 79.73%
2 years (2018-12-02) N/A
3 years (2017-12-02) N/A
5 years (2015-12-02) N/A

IDEAYA Biosciences financials

Gross profit TTM USD$0
Return on assets TTM -18.88%
Return on equity TTM -31.56%
Profit margin 0%
Book value $6.333
Market capitalisation USD$389 million

TTM: trailing 12 months

Shorting IDEAYA Biosciences shares

There are currently 686,959 IDEAYA Biosciences shares held short by investors – that's known as IDEAYA Biosciences's "short interest". This figure is 17.9% up from 582,707 last month.

There are a few different ways that this level of interest in shorting IDEAYA Biosciences shares can be evaluated.

IDEAYA Biosciences's "short interest ratio" (SIR)

IDEAYA Biosciences's "short interest ratio" (SIR) is the quantity of IDEAYA Biosciences shares currently shorted divided by the average quantity of IDEAYA Biosciences shares traded daily (recently around 159387.23897912). IDEAYA Biosciences's SIR currently stands at 4.31. In other words for every 100,000 IDEAYA Biosciences shares traded daily on the market, roughly 4310 shares are currently held short.

However IDEAYA Biosciences's short interest can also be evaluated against the total number of IDEAYA Biosciences shares, or, against the total number of tradable IDEAYA Biosciences shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case IDEAYA Biosciences's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 IDEAYA Biosciences shares in existence, roughly 20 shares are currently held short) or 0.0357% of the tradable shares (for every 100,000 tradable IDEAYA Biosciences shares, roughly 36 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against IDEAYA Biosciences.

Find out more about how you can short IDEAYA Biosciences stock.

IDEAYA Biosciences share dividends

We're not expecting IDEAYA Biosciences to pay a dividend over the next 12 months.

IDEAYA Biosciences overview

IDEAYA Biosciences, Inc., an oncology-focused precision medicine company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's product candidate is IDE196, a protein kinase C inhibitor that is in Phase 1/2 clinical trial for genetically-defined cancers having GNAQ or GNA11 gene mutations. Its preclinical pipeline includes various synthetic lethality programs targeting MAT2A for solid tumors with MTAP deletions; Pol-theta in tumors with homologous recombination deficiency, including BRCA mutations; PARG in tumors with BRCA2 mutations in base excision repair; and WRN in high microsatellite instability tumors. The company has a research collaboration agreement with Cancer Research UK and the University of Manchester to develop small molecule inhibitors of Poly (ADP-ribose) glycohydrolase; and a clinical trial collaboration and supply agreement with Pfizer Inc. for Phase 1/2 study in metastatic uveal melanoma and other solid tumors, as well as a strategic partnership with GlaxoSmithKline plc. IDEAYA Biosciences, Inc. was founded in 2015 and is headquartered in South San Francisco, California.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site